ANAshwin N. AnanthakrishnanAug 1, 2026New paperautoPaperMirikizumab treatment decreases ulcerative colitis-related surgery and hospitalisation rates: 4-year LUCENT studies resultsZeitschrift für Gastroenterologie · 2026 · Fernando Magro, Ashwin N. Ananthakrishnan, Takayoshi Kobayashi et al.